Log in
Enquire now
‌

US Patent 8058250 Methods and compositions involving miRNA and miRNA inhibitor molecules

Patent 8058250 was granted and assigned to Asuragen on November, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Asuragen
Asuragen
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8058250
Patent Inventor Names
Rich Jarvis0
Kevin Kelnar0
Lance Ford0
Mike Byrom0
Angie Cheng0
David Brown0
Dmitriy Ovcharenko0
Eric Devroe0
Date of Patent
November 15, 2011
Patent Application Number
11837488
Date Filed
August 10, 2007
Patent Primary Examiner
‌
Brian Whiteman
Patent abstract

The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying miRNAs with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8058250 Methods and compositions involving miRNA and miRNA inhibitor molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.